SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

McDonald's Corp. engages in the operation and franchising of restaurants. The firm operates through the following segments: U.S., International Operated Markets, and International Developmental Licensed Markets and Corporate. The U.S. segment focuses its operations on the United States. The International Operated Markets segment consists of operations and the franchising of restaurants in Australia, Canada, France, Germany, Italy, the Netherlands, Russia, Spain, and the U.K. The International Developmental Licensed Markets and Corporate segment consists of developmental licensee and affiliate markets in the McDonald’s system. Its products include Big Mac, Quarter Pounder with Cheese, Filet-O-Fish, several chicken sandwiches, Chicken McNuggets, wraps, McDonald's Fries, salads, oatmeal, shakes, McFlurry desserts, sundaes, soft serve cones, pies, soft drinks, coffee, and McCafe beverages. The company was founded by Raymond Albert Kroc on April 15, 1955 and is headquartered in Chicago, IL.

McDonald`s Corp

McDonald's Corp

McDonald's is facing significant downward pressure as traders react to persistent concerns over weak restaurant traffic, high inflation, and a difficult consumer spending environment. While some investors view the stock's slide to 52-week lows as a long-term value opportunity and a chance to accumulate shares for the dividend, sentiment remains divided with many traders warning of further downside.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

Investors are expressing significant frustration over consistent downward pressure and dilution, while bulls remain focused on the company's recent acquisition of LivePerson and potential for long-term growth despite high short interest.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceX is trending due to heightened volatility and speculative interest ahead of the upcoming Starship orbital test flight, coupled with institutional rebalancing activity and recent analyst commentary on the company's long-term valuation potential. Traders remain sharply divided, debating whether the stock is a long-term growth opportunity or currently overvalued amid broader market uncertainty surrounding potential interest rate changes.

Red Cat Holdings, Inc. provides products, services and solutions to the drone industry. It also engages in the provision of distributed data storage, analytics and services for the drone industry.The firm product include Dronebox, which is a blockchain technology that records, stores and analyzes flight data and information from a drone. It operates through the Enterprise Segment. The Enterprise Segment will focus on developing a hardware enabled software platform of services and solutions to government and commercial enterprises and the military. The company was founded by Jeffrey M. Thompson in February 1984 and is headquartered in San Juan, Puerto Rico.

Red Cat Holdings Inc

Red Cat Holdings is facing significant downward pressure as investors grow frustrated with the company's lack of confirmed major contracts and what many describe as vague leadership communication. While some traders are positioning for potential developments in drone-related defense programs and recent sector-wide tariffs, others remain skeptical, citing persistent financial losses and ongoing share dilution.

Starbucks Corp. engages in the production, marketing, and retailing of specialty coffee. It operates through the following segments: North America, International, and Channel Development. The North America segment focuses on the United States and Canada. The International segment is involved in China, Japan, Asia Pacific, Europe, Middle East, Africa, Latin America, and Caribbean. The Channel Development segment includes roasted whole bean and ground coffees, Seattle’s Best Coffee, and Teavana-branded single-serve products. The company was founded by Jerry Baldwin and Howard D. Schultz on November 4, 1985, and is headquartered in Seattle, WA.

Starbucks Corp.

Starbucks Corp

Starbucks is trending as traders react to reports that the company is exploring a potential sale of a majority stake in its Japan business, a move aimed at pursuing an asset-light strategy similar to its recent restructuring in China. While some investors view the operational turnaround and focus on afternoon traffic as catalysts for growth, others remain cautious, citing increased competition, valuation concerns, and broader macroeconomic pressures on consumer discretionary spending.

Forgent Power Solutions, Inc. is a holding company, which engages in the design and manufacture of electrical distribution equipment used in data centers, power grid, and energy-intensive industrial facilities. It also offers powertrain solutions and standard and custom products. The company was founded on July 21, 2025 and is headquartered in Dayton, MN.

Forgent Power Solutions Inc. - Ordinary Shares - Class A

Forgent Power Solutions Inc.

Forgent Power Solutions is trending following a strong fourth-quarter earnings report, where the company exceeded adjusted earnings and revenue estimates while providing fiscal 2027 guidance that surpassed analyst expectations. Investors are particularly focused on the company's record $3 billion backlog and expansion plans, with multiple analysts issuing price target upgrades following the results.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals is trending following positive Phase 3 SHASTA-3 and SHASTA-4 study results for plozasiran in patients with severe hypertriglyceridemia, which met all primary and secondary endpoints. While the community reaction is overwhelmingly bullish regarding the company's platform validation and clinical progress, some traders expressed frustration over recent price volatility, attributing it to broader sector weakness or institutional trading behavior.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including sellers, advertising, and subscription services through internationally focused online stores. The AWS segment is composed of global sales of computers, storage, databases, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon is facing downward pressure amid reports that AWS cannot recover customer data from Middle Eastern server facilities damaged during the conflict in the region. Traders are also expressing ongoing frustration with the stock's recent underperformance relative to other mega-cap peers and are monitoring the broader market impact of rising Treasury yields and the upcoming Federal Reserve policy decision.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending due to renewed market speculation regarding a potential buyout, which has been fueled by circulating rumors of interest from a larger biopharma company. While investors debate the credibility of these reports and the potential valuation, the conversation also centers on the company's strong commercial momentum and the upcoming trial data for its subcutaneous treatment.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are experiencing sustained selling pressure, with the community expressing frustration over the stock's recent performance despite positive earnings results and analyst sentiment. Traders are closely monitoring potential catalysts including news regarding a sovereign cloud contract in Japan and the valuation of OpenAI's upcoming funding round as factors that could impact the company's cloud growth narrative.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eli Lilly To Present Fresh Data On Foundayo, Retatrutide In Europe – Here’s Why Berenberg Sees A 21% Potential Upside In LLY Stock

Eli Lilly is trending as investors react to a strong earnings report featuring a beat-and-raise of guidance, fueled by robust demand for Mounjaro and Zepbound. The sentiment is largely bullish, with analysts increasing price targets while the company maintains its lead in the obesity drug market.

Novo Nordisk Taps Anthropic’s Claude Science To Speed Up Drug Discovery — Here’s Everything Investors Need To Know

Equity

Novo will use Anthropic’s Claude Science in R&D to tackle scientific and drug discovery challenges, aiming to develop new medicines faster.


Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It

Zacks.com users have recently been watching Lilly (LLY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

NVO To Present Fresh Data From Blockbuster Wegovy Pill At European Conference As Rival Eli Lilly Readies Its Own Obesity Updates

Novo said it will present 44 abstracts at the European Association for the Study of Diabetes symposium later this month.


Eli Lilly's Momentum Looks Unstoppable -- but 1 Factor Could Change Everything

Key PointsEli Lilly's breakthroughs in its core therapeutic area are driving excellent financial results...

Can Redwire's Microgravity Platform Expand Commercial Opportunities?

RDW turns microgravity into a commercial platform, spanning pharmaceutical research, biotechnology and advanced manufacturing.

Berenberg sees potential upside to Lilly’s full-year 2026 revenue forecast, which ranges from $85 billion to $87 billion.


Eli Lilly Stock Gains as Retatrutide and Foundayo Data Highlight Pipeline Strength

Shares of Eli Lilly and Company are trading higher Tuesday following positive previews of its late-stage obesity and diabetes pipeline.read more...

Futures Drop As Yields, Oil Prices Keep Rising

Futures Drop As Yields, Oil Prices Keep Rising

 Futures are lower - but well off session lows thanks to some well-time oil sell orders just before US traders walked in to work - as bond yields continue to make new highs, with both Nasdaq and Russell lagging the S&P which feels like...

Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health

Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic healthPR...

Can Viking Therapeutics Beat Big Pharma With Monthly Weight-Loss Shots? Here’s The Risk CEO Says Could Derail It

CEO Brian Lian said monthly VK2735 must preserve weight loss without restarting nausea, vomiting and other gastrointestinal effects.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Bearish Sentiment

$AMD

$SHOP

$UBER

$LLY

$AMD, $SHOP, $UBER, and $LLY are four of the most searched and talked-about stocks among retail investors this morning. Which are you most bullish on? Drop your reasoning in the comments.

Which of these trending stocks are you most bullish on for the next 5 years - $AMD, $SHOP, $UBER, or $LLY? 
 
Explain why in the comments.

Stocktwits

Advanced Micro Devices Inc

Shopify Inc

Uber Technologies Inc

Which of these trending stocks are you most bullish on for the next 5 years - 

Stocktwits Polls

Wall Street is turning hyper-bullish, with new price targets reaching up to $1,400 citing dominant GLP-1 demand and massive growth potential.

Strategic AI partnerships, including a new collaboration with Twist Bioscience, are accelerating the pace of pipeline discovery and drug characterization.

Recent prescription data shows impressive week-over-week growth as this new oral drug rapidly captures market share from primary obesity competitors.

Market speculation is heating up around potential acquisitions as the firm aggressively utilizes its windfall cash to secure experimental pipelines.

Current Price	$1,141.09
Prev Close	$1,136.11
Open	$1,138.01
Dividend Yield	0.56%
50-Day Moving Average	$1,181.86
Beta	0.68
Avg. Volume	2.86M
PE Ratio	38.60

52-Week High	$1,292.65
52-Week Low	$712.05
Market Capitalization	$1.07T
EPS (Annual)	$22.95
Price to Book	31.57
Revenue Per Employee	$1.3M

Feed

News

Sentiment

Earnings

NewFutures

Fundamentals

Info

LLY Fundamentals